Nonalcoholic fatty liver disease: pathology and pathogenesis.
暂无分享,去创建一个
[1] E. Brunt,et al. Nonalcoholic fatty liver disease. , 2010, Clinics in liver disease.
[2] A. Feldstein,et al. Nonalcoholic steatohepatitis in children: A multicenter clinicopathological study , 2009, Hepatology.
[3] H. Robenek,et al. Compartmentalization of proteins in lipid droplet biogenesis. , 2009, Biochimica et biophysica acta.
[4] L. Ferrucci,et al. Inflammation and Race and Gender Differences in Computerized Tomography‐measured Adipose Depots , 2009, Obesity.
[5] K. Isse,et al. Epithelial–mesenchymal transition induced by biliary innate immunity contributes to the sclerosing cholangiopathy of biliary atresia , 2009, The Journal of pathology.
[6] Xiaoping Hu,et al. Quantitative analysis of T2‐correction in single‐voxel magnetic resonance spectroscopy of hepatic lipid fraction , 2009, Journal of magnetic resonance imaging : JMRI.
[7] V. Paradis,et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis , 2009, Hepatology.
[8] A. Dolganiuc,et al. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet‐induced nonalcoholic steatohepatitis model in mice , 2009, Hepatology.
[9] S. Grundy,et al. Ethnic differences in hepatic steatosis: An insulin resistance paradox? , 2009, Hepatology.
[10] B. Neuschwander‐Tetri,et al. Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): A histologic marker of advanced NAFLD—Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network , 2009, Hepatology.
[11] A. Feldstein,et al. Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease , 2009, Journal of Biological Chemistry.
[12] N. Chalasani,et al. Nonalcoholic fatty liver disease and cardiovascular risk , 2009, Current gastroenterology reports.
[13] J. Capeau,et al. Insulin resistance and steatosis in humans. , 2008, Diabetes & metabolism.
[14] M. V. Van Natta,et al. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. , 2008, Gastroenterology.
[15] A. Diehl,et al. Mechanisms of disease progression in nonalcoholic fatty liver disease. , 2008, Seminars in liver disease.
[16] G. Chejfec,et al. Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? , 2008, Archives of pathology & laboratory medicine.
[17] M. Yeh,et al. Animal models of NASH: Getting both pathology and metabolic context right , 2008, Journal of gastroenterology and hepatology.
[18] Xiong Ma,et al. Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. , 2008, Journal of hepatology.
[19] B. Neuschwander‐Tetri,et al. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[20] Gregory Gores1,et al. Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease , 2008, Seminars in liver disease.
[21] A. Feldstein,et al. Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive , 2008, Seminars in liver disease.
[22] B. Roe,et al. A core gut microbiome in obese and lean twins , 2008, Nature.
[23] W. Nseir,et al. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. , 2008, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[24] G. Godlewski,et al. Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations. , 2008, Hypertension.
[25] N. Anderson,et al. Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis , 2008, Pharmacological Reviews.
[26] R. Xu,et al. Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study , 2008, The American Journal of Gastroenterology.
[27] M. Omary,et al. The genetic background modulates susceptibility to mouse liver Mallory‐Denk body formation and liver injury , 2008, Hepatology.
[28] Fritz Schick,et al. Identification and characterization of metabolically benign obesity in humans. , 2008, Archives of internal medicine.
[29] S. Bischoff,et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. , 2008, The Journal of nutrition.
[30] J. Maher,et al. Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis , 2008, Hepatology.
[31] J. Kench,et al. Visceral fat: A key mediator of steatohepatitis in metabolic liver disease , 2008, Hepatology.
[32] J. Kimmons,et al. Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. , 2008, Medscape journal of medicine.
[33] M. Manco,et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial , 2008, Hepatology.
[34] Z. Younossi,et al. Review article: current management of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis , 2008, Alimentary pharmacology & therapeutics.
[35] A. Rissanen,et al. Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study. , 2008, European heart journal.
[36] S. Friedman,et al. The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. , 2008, Gastroenterology.
[37] D. Mozaffarian,et al. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. , 2008, Clinical chemistry.
[38] E. Parks,et al. Dietary sugars stimulate fatty acid synthesis in adults. , 2008, The Journal of nutrition.
[39] G. Lippi,et al. NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men , 2008, Obesity.
[40] C. McClain,et al. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. , 2008, Journal of hepatology.
[41] J. Sheeder,et al. Presence of the metabolic syndrome in obese adolescents predicts impaired glucose tolerance and nonalcoholic fatty liver disease. , 2008, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[42] S. McCall,et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. , 2008, Journal of hepatology.
[43] A. Baranova,et al. A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH) , 2008, Obesity surgery.
[44] Wendy S. Wright,et al. Fat-specific Protein 27 Regulates Storage of Triacylglycerol* , 2008, Journal of Biological Chemistry.
[45] C. Day,et al. Genes and nonalcoholic fatty liver disease , 2008, Current diabetes reports.
[46] G. Gores,et al. The lysosomal‐mitochondrial axis in free fatty acid–induced hepatic lipotoxicity , 2008, Hepatology.
[47] S. Stannard,et al. Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders , 2008, Hepatology.
[48] B. Antonsson,et al. Mechanism of mitochondrial glutathione-dependent hepatocellular susceptibility to TNF despite NF-kappaB activation. , 2008, Gastroenterology.
[49] K. Zatloukal,et al. Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis. , 2008, Journal of hepatology.
[50] B. S. Mohammed,et al. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. , 2008, Gastroenterology.
[51] G. Musso,et al. Should Nonalcoholic Fatty Liver Disease Be Included in the Definition of Metabolic Syndrome? A Cross-Sectional Comparison With Adult Treatment Panel III Criteria in Nonobese Nondiabetic Subjects , 2008, Diabetes Care.
[52] O. Izaola,et al. Influence of Insulin Resistance and Adipokines in the Grade of Steatosis of Nonalcoholic Fatty Liver Disease , 2008, Digestive Diseases and Sciences.
[53] B. Neuschwander‐Tetri,et al. Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels. , 2008, Archives of internal medicine.
[54] M. Sherman,et al. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. , 2008, Journal of hepatology.
[55] A. Baranova,et al. Adipokines and cytokines in non‐alcoholic fatty liver disease , 2007, Alimentary pharmacology & therapeutics.
[56] J. Crespo,et al. Lipopolysaccharide-Binding Protein Plasma Levels and Liver TNF-Alpha Gene Expression in Obese Patients: Evidence for the Potential Role of Endotoxin in the Pathogenesis of Non-Alcoholic Steatohepatitis , 2007, Obesity surgery.
[57] Tongzheng Liu,et al. Sensitivity of mice to lipopolysaccharide is increased by a high saturated fat and cholesterol diet , 2007, Journal of Inflammation.
[58] M. Omary,et al. Keratins let liver live: Mutations predispose to liver disease and crosslinking generates Mallory‐Denk bodies , 2007, Hepatology.
[59] P. Clavien,et al. Omega 3 - Omega 6: What is right for the liver? , 2007, Journal of hepatology.
[60] B. Neuschwander‐Tetri,et al. The effects of 48 weeks of rosiglitazone on hepatocyte mitochondria in human nonalcoholic steatohepatitis , 2007, Hepatology.
[61] Jing Ye,et al. Cideb Regulates Diet-Induced Obesity, Liver Steatosis, and Insulin Sensitivity by Controlling Lipogenesis and Fatty Acid Oxidation , 2007, Diabetes.
[62] Michelle M Wiest,et al. A lipidomic analysis of nonalcoholic fatty liver disease , 2007, Hepatology.
[63] C. McClain,et al. Palmitic acid induces production of proinflammatory cytokine interleukin‐8 from hepatocytes , 2007, Hepatology.
[64] James E. Nelson,et al. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis , 2007, Hepatology.
[65] J. Schwimmer. Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents. , 2007, Seminars in liver disease.
[66] H. Tilg,et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. , 2007, Gastroenterology.
[67] K. Zatloukal,et al. From Mallory to Mallory-Denk bodies: what, how and why? , 2007, Experimental cell research.
[68] C. McClain,et al. Good fat/bad fat , 2007, Hepatology.
[69] S. McCall,et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis , 2007, Hepatology.
[70] Hirokazu Takahashi,et al. Telmisartan, An Angiotensin II Type 1 Receptor Blocker, Controls Progress of Nonalcoholic Steatohepatitis in Rats , 2007, Digestive Diseases and Sciences.
[71] Philipp E. Scherer,et al. Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans , 2007, Diabetes.
[72] T. Therneau,et al. The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.
[73] C. McClain,et al. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. , 2007, The Journal of nutritional biochemistry.
[74] E. Roberts,et al. Non-alcoholic steatohepatitis in children. , 2007, Clinics in liver disease.
[75] J. Sheeder,et al. 34: Presence of the metabolic syndrome (MS) in obese adolescents predicts impaired glucose tolerance (IGT) and fatty liver disease , 2007 .
[76] Parvez Hossain,et al. Obesity and diabetes in the developing world--a growing challenge. , 2007, The New England journal of medicine.
[77] A. Gerbes,et al. Role of Kupffer cells in host defense and liver disease , 2006, Liver international : official journal of the International Association for the Study of the Liver.
[78] F. Schick,et al. The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity. , 2006, Clinical chemistry.
[79] Jeffrey B. Schwimmer,et al. Prevalence of Fatty Liver in Children and Adolescents , 2006, Pediatrics.
[80] D. Nelson,et al. Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[81] Y. Le Marchand-Brustel,et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. , 2006, Gastroenterology.
[82] P. Ciampalini,et al. NAFLD in children: A prospective clinical‐pathological study and effect of lifestyle advice , 2006, Hepatology.
[83] Kohjiro Ueki,et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. , 2006, The Journal of clinical investigation.
[84] Lisa M Yerian,et al. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease , 2006, Hepatology.
[85] S. Caldwell,et al. Enlarged Hepatocytes in NAFLD Examined with Osmium Fixation: Does Microsteatosis Underlie Cellular Ballooning in NASH? , 2006, The American Journal of Gastroenterology.
[86] J. Schölmerich,et al. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. , 2006, Journal of molecular endocrinology.
[87] Robert A Fisher,et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C , 2006, Hepatology.
[88] L. Sechi,et al. Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. , 2006, The Journal of clinical endocrinology and metabolism.
[89] S. Harrison. New treatments for nonalcoholic fatty liver disease , 2006, Current gastroenterology reports.
[90] G. Gores,et al. Apoptosis and necrosis in the liver: A tale of two deaths? , 2006, Hepatology.
[91] H. Cortez‐Pinto,et al. Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis , 2006, European journal of gastroenterology & hepatology.
[92] C. McClain,et al. Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease. , 2005, The Journal of pediatrics.
[93] F. Marra,et al. Review article: the pathogenesis of fibrosis in non‐alcoholic steatohepatitis , 2005, Alimentary pharmacology & therapeutics.
[94] D. Koop,et al. Steatohepatitis induced by intragastric overfeeding in mice , 2005, Hepatology.
[95] M. Laakso,et al. The CIDEA gene V115F polymorphism is associated with obesity in Swedish subjects. , 2005, Diabetes.
[96] A. Baranova,et al. A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease , 2005, Hepatology.
[97] C. Nievergelt,et al. Histopathology of pediatric nonalcoholic fatty liver disease , 2005, Hepatology.
[98] D. Pessayre,et al. NASH: a mitochondrial disease. , 2005, Journal of hepatology.
[99] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[100] J. Jessurun,et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.
[101] M. Manos,et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease , 2005, Hepatology.
[102] S. Shoelson,et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.
[103] A. Diehl,et al. Cytokines and the pathogenesis of non-alcoholic steatohepatitis , 2005, Gut.
[104] Jonathan C. Cohen,et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.
[105] A. McCullough,et al. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. , 2004, Clinics in liver disease.
[106] L. Krugner-Higby,et al. Mitochondria in nonalcoholic fatty liver disease. , 2004, Clinics in liver disease.
[107] A. Diehl. Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease. , 2004, Clinics in liver disease.
[108] D. Befroy,et al. Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease* , 2004, Journal of Biological Chemistry.
[109] G. Gores,et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF‐α expression via a lysosomal pathway , 2004 .
[110] J. Kench,et al. Beyond insulin resistance in NASH: TNF‐α or adiponectin? , 2004, Hepatology.
[111] R. Rodrigo,et al. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. , 2004, Clinical science.
[112] R. Townsend,et al. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. , 2004, The Journal of clinical endocrinology and metabolism.
[113] A. Lonardo,et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver , 2004, Hepatology.
[114] S. Caldwell,et al. The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis , 2004, Hepatology.
[115] K. Mak,et al. Model of nonalcoholic steatohepatitis. , 2004, The American journal of clinical nutrition.
[116] L. Burgart,et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial , 2004, Hepatology.
[117] T. Roskams,et al. Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease , 2004, Hepatology.
[118] M. Beylot,et al. Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. , 2003, Diabetes & metabolism.
[119] Sheng-Cai Lin,et al. Cidea-deficient mice have lean phenotype and are resistant to obesity , 2003, Nature Genetics.
[120] C. McClain,et al. Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E , 2003, Hepatology.
[121] James G Kench,et al. Long‐term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C , 2003, Hepatology.
[122] Yu Wang,et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. , 2003, The Journal of clinical investigation.
[123] Christopher J. Lyon,et al. Minireview: adiposity, inflammation, and atherogenesis. , 2003, Endocrinology.
[124] G. Gores,et al. Apoptotic Body Engulfment by a Human Stellate Cell Line Is Profibrogenic , 2003, Laboratory Investigation.
[125] A. Moser,et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease , 2003, Hepatology.
[126] E. Kabagambe,et al. Adipose tissue biomarkers of fatty acid intake. , 2002, The American journal of clinical nutrition.
[127] Erick M Remer,et al. The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.
[128] J. Lefkowitch,et al. Kupffer Cell Aggregation and Perivenular Distribution in Steatohepatitis , 2002, Modern Pathology.
[129] Joseph L Goldstein,et al. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.
[130] V. Paradis,et al. High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis , 2001, Hepatology.
[131] J. Crespo,et al. Are there Predictive Factors of Severe Liver Fibrosis in Morbidly Obese Patients with Non-alcoholic Steatohepatitis? , 2001, Obesity surgery.
[132] J. Clore,et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. , 2001, Gastroenterology.
[133] J. Lavine. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. , 2000, The Journal of pediatrics.
[134] K. Zatloukal,et al. Mallory bodies revisited. , 2000, Journal of hepatology.
[135] G. Hegedűs. [Pathology of alcoholic liver disease]. , 2000, Orvosi hetilap.
[136] K. Batts,et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis , 1999, Hepatology.
[137] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.
[138] A. Burt,et al. Diagnosis and interpretation of steatosis and steatohepatitis. , 1998, Seminars in diagnostic pathology.
[139] C. Day,et al. Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.
[140] M. Clemens,et al. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[141] M. Bennett,et al. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver , 1995, The Lancet.
[142] R. Simsolo,et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.
[143] P. Scheuer,et al. The pathology of diabetic hepatitis , 1988, The Journal of pathology.
[144] C. M. Leevy. FATTY LIVER: A STUDY OF 270 PATIENTS WITH BIOPSY PROVEN FATTY LIVER AND A REVIEW OF THE LITERATURE , 1962 .
[145] R. Brůha,et al. Alcoholic liver disease. , 2012, World journal of hepatology.
[146] E. Brunt,et al. CHAPTER 41 – Fatty Liver Disease , 2009 .
[147] Hui Chen,et al. Consequences of lipid droplet coat proteins down – regulation in liver cells : Abnormal lipid droplet metabolism and induction of insulin resistance , 2008 .
[148] S. Friedman. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. , 2008, Physiological reviews.
[149] P. Schirmacher,et al. Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis , 2008 .
[150] H. Cortez‐Pinto,et al. Non-alcoholic steatohepatitis: from cell biology to clinical practice. , 2006, Journal of hepatology.
[151] C. Day. From fat to inflammation. , 2006, Gastroenterology.
[152] G. Farrell,et al. LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis , 2006 .
[153] E. Keeffe,et al. Chapter Thirty-Six – Alcoholic and nonalcoholic fatty liver disease , 2006 .
[154] M. Camilo,et al. Nonalcoholic steatohepatitis , 2005, Digestive Diseases and Sciences.
[155] S. Sanderson,et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. , 2005, Journal of hepatology.
[156] H. Minuk,et al. Metabolic syndrome. , 2005, Journal of insurance medicine.
[157] S. Locarnini. Molecular virology of hepatitis B virus. , 2004, Seminars in liver disease.
[158] Brian P. Mulhall,et al. Nonalcoholic steatohepatitis , 2004, Current treatment options in gastroenterology.
[159] J. Schwarz,et al. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. , 2003, The American journal of clinical nutrition.
[160] D. Pessayre,et al. Mitochondria in Steatohepatitis , 2001, Seminars in liver disease.
[161] A. Diehl,et al. Animal Models of Steatosis , 2001, Seminars in liver disease.
[162] F. Schaffner,et al. Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.